Surgery Partners (SGRY) revenue and earnings history
Surgery Partners reported revenue of $3.31B for fiscal 2025 (year ended Dec 31, 2025), +6.2% on the year before, and net income of −$77.9M.
Over 12 years, from fiscal 2013 to fiscal 2025, revenue grew at a compound rate of +22.7% a year.
Revenue and net income, 12 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $3.31B+6.2% | $390M | −$77.9M | $274M | $78.7M | $196M | $14.8M | — | — | $240M | $3.74B | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Surgery Partners (SGRY) on OQRO.
Common questions
What was Surgery Partners's revenue in fiscal 2025?
$3.31B for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 2, 2026. That is +6.2% on fiscal 2024 ($3.11B).
How fast has Surgery Partners's revenue grown?
From $285M in fiscal 2013 to $3.31B in fiscal 2025: a compound annual growth rate of +22.7% over 12 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Surgery Partners tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.